Latest Europe News

Dimerix Limited has announced a US licensing transaction for its Phase 3 asset DMX-200 targeting FSGS, alongside progress updates on its clinical trial. The move underscores the company’s push to address a rare kidney disease with no approved therapies.

Imricor Medical Systems has initiated its first MRI-guided atrial flutter ablation procedures at Semmelweis University in Budapest, marking a significant expansion of its real-time MRI technology in Europe.

Memphasys Limited has completed a pivotal Phase III trial confirming its Felix™ System as best-in-class for sperm separation, while advancing regulatory and commercial efforts in China and Brazil supported by fresh capital.

HeraMED reports strong Q1 FY25 progress with 4,282 registered users on its HeraCARE platform, a new collaboration with Garmin Health, and advancing commercial deals in the US and Europe. Early clinical data suggests improved maternal outcomes and operational efficiencies.

Infinity Lithium has acquired full ownership of four high-grade gold-silver-copper exploration projects in Victoria’s Lachlan Fold Belt and secured options on additional nearby assets, while its flagship San José lithium project in Spain faces extended regulatory timelines and funding setbacks.

Lithium Universe Limited has delivered a robust Definitive Feasibility Study for its Bécancour Lithium Carbonate Refinery, confirming strong economic viability and progressing toward project funding and strategic collaborations.

Harvest Technology Group reported a 19% improvement in normalized EBITDA for Q3 FY25 alongside a $1.6 million capital raise, reinforcing its strategic plan to achieve profitability by FY27.

Talga Group advances its European battery materials ambitions with EU Strategic Project recognitions for its graphite mine and anode refinery, alongside a €70 million Innovation Fund grant.

SomnoMed Limited reported a robust 23.2% revenue increase in Q3 FY25, reaffirming its full-year guidance while actively addressing new US tariffs through potential duty-free exemptions.

4DS Memory Limited has successfully manufactured its first 20nm memory cell array, marking a pivotal step in its ReRAM technology development, while raising $8.6 million through a placement and Share Purchase Plan to fuel ongoing innovation.

Dimerix Limited advances its Phase 3 kidney disease trial with FDA acceptance of proteinuria as a primary endpoint and clinches a lucrative licensing agreement in Japan worth up to AU$107 million plus royalties.

Ionic Rare Earths reports major strides in sustainable magnet recycling and heavy rare earth projects, backed by strategic partnerships and a sharp reduction in losses.